Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathy.
Recently, we completed a second biostatistical study of urinary tract tumors (UTT) in areas with Balkan endemic nephropathy (BEN) in the Vratza district, Bulgaria, during the period 1975 to 1991. We confirmed the positive correlation between the incidence of urinary tract tumors (UTT) and BEN demonstrated in our first population-based case control 1977 study. A UTT incidence of 98.9 per 100,000 men and 74.7 per 100,000 women was found in villages most affected by BEN when compared with 11.0 and 6.7 for men and women, respectively, in nonendemic villages. The relative risk (RR) of UTT in BEN villages showed tumors of kidney pelvis and ureters-29 in men and 35 in women and urinary bladder tumors-4 in men and 11 in women. The percentage of food and blood samples containing nephrotoxic and carcinogenic mycotoxin Ochratoxin A (OTA) correlated with the origin of the samples. The most contaminated samples were found in BEN villages and households, and the urinary excretion of OTA was higher in the group of BEN/UTT patients. The UTT DNA's were studied by the 32P-postlabeling method for the presence of OTA-DNA adducts. Some OTA-DNA adducts characteristic for endemic UTT and absent in control nonendemic UTT and nontumorous tissues were described for the first time.
Nikolov
I G
IG
National Oncological Centre, Sofia, Bulgaria.
Petkova-Bocharova
D
D
Castegnaro
M
M
Pfohl-Leskowicz
A
A
Gill
C
C
Day
N
N
Chernozemsky
I N
IN
D000818:Animals; D001449:Balkan Nephropathy / Q000139:chemically induced / Q000453:epidemiology*; D002031:Bulgaria / Q000453:epidemiology; D002273:Carcinogens / Q000009:adverse effects; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D018736:DNA Adducts / Q000032:analysis; D002523:Edible Grain / Q000009:adverse effects; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D051379:Mice; D009183:Mycotoxins / Q000009:adverse effects; D009793:Ochratoxins / Q000009:adverse effects; D014571:Urologic Neoplasms / Q000139:chemically induced / Q000453:epidemiology*
D002273:Carcinogens; D018736:DNA Adducts; D009183:Mycotoxins; D009793:Ochratoxins; C025589:ochratoxin A